Xiang Li

Xiang Li is currently a Principal Scientist at AbbVie, specializing in siRNA delivery and therapeutics since September 2025. Prior to this role, Xiang held several positions at Entrada Therapeutics from August 2019 to September 2025, including Director and Associate Director of Discovery Research, as well as Senior Research Scientist. Experience includes working as an Applied Research Scientist at InfinixBio, and a Research Scientist at Parabon NanoLabs Inc. Earlier in the career, Xiang served as a Postdoc Fellow at the University of Michigan and earned a PhD in Analytical Chemistry from Purdue University, where the focus was on bionanotechnology and DNA/RNA nanostructures. A Bachelor's degree in Chemistry and Biology was obtained from Tsinghua University, which involved research on titanium dioxide nanostructures for solar cells and biomolecule detection.